| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.761 | 0.022 | 0.815 | Apoptosis agonist | 0.815 0.015 CID_154699852 | CID_154699852 | |
| 0.625 | 0.028 | 0.873 | Transcription factor NF kappa B inhibitor | 0.873 0.008 CID_154699852 | CID_154699852 | |
| 0.635 | 0.044 | 0.836 | Antiinflammatory | 0.836 0.011 CID_154699852 | CID_154699852 | |
| 0.528 | 0.014 | 0.682 | Nitric oxide antagonist | 0.682 0.006 CID_154699852 | CID_154699852 | |
| 0.519 | 0.02 | 0.557 | Immunomodulator | 0.557 0.016 CID_154699852 | CID_154699852 | |
| 0.532 | 0.049 | 0.635 | Caspase 9 stimulant | 0.635 0.032 CID_154699852 | CID_154699852 | |
| 0.392 | 0.003 | 0.392 | Estrogen receptor alpha agonist | 0.125 0.006 CID_154699852 | ||
| 0.417 | 0.039 | 0.43 | Caspase 3 stimulant | 0.43 0.035 CID_154699852 | CID_154699852 | |
| 0.373 | 0.002 | 0.373 | Ca(v)3.1 blocker | 0.081 0.057 CID_154699852 | ||
| 0.38 | 0.01 | 0.38 | Lipocortins synthesis antagonist | 0.314 0.019 CID_154699852 | ||
| 0.387 | 0.018 | 0.462 | Anesthetic general | 0.462 0.01 CID_154699852 | CID_154699852 | |
| 0.363 | 0.003 | 0.363 | Estrogen receptor beta agonist | 0.185 0.005 CID_154699852 | ||
| 0.357 | 0.003 | 0.357 | Pregnane X receptor agonist | |||
| 0.346 | 0.003 | 0.346 | Transcription factor NF kappa B stimulant | 0.322 0.004 CID_154699852 | ||
| 0.368 | 0.03 | 0.368 | Sodium/bile acid cotransporter inhibitor | 0.323 0.059 CID_154699852 | ||
| 0.338 | 0.005 | 0.338 | Estrogen agonist | 0.193 0.008 CID_154699852 | ||
| 0.399 | 0.077 | 0.691 | Antibacterial | 0.691 0.009 CID_154699852 | CID_154699852 | |
| 0.379 | 0.072 | 0.529 | Immunosuppressant | 0.529 0.026 CID_154699852 | CID_154699852 | |
| 0.312 | 0.013 | 0.312 | Interleukin 6 antagonist | 0.297 0.015 CID_154699852 | ||
| 0.352 | 0.063 | 0.656 | Cholesterol antagonist | 0.656 0.012 CID_154699852 | CID_154699852 | |
| 0.304 | 0.019 | 0.477 | Interferon gamma antagonist | 0.477 0.007 CID_154699852 | CID_154699852 | |
| 0.251 | 0.018 | 0.251 | Cholesterol synthesis inhibitor | 0.221 0.022 CID_154699852 | ||
| 0.226 | 0.011 | 0.226 | Androgen antagonist | |||
| 0.227 | 0.013 | 0.227 | Arachidonic acid antagonist | 0.196 0.037 CID_154699852 | ||
| 0.226 | 0.015 | 0.254 | Microtubule formation inhibitor | 0.254 0.008 CID_154699852 | CID_154699852 | |
| 0.239 | 0.029 | 0.375 | Protein kinase stimulant | 0.375 0.01 CID_154699852 | CID_154699852 | |
| 0.252 | 0.043 | 0.498 | Hepatoprotectant | 0.498 0.007 CID_154699852 | CID_154699852 | |
| 0.223 | 0.013 | 0.223 | Ca(v)2.2 blocker | |||
| 0.211 | 0.004 | 0.211 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.21 | 0.019 | 0.387 | Antineoplastic antibiotic | 0.387 0.005 CID_154699852 | CID_154699852 | |
| 0.2 | 0.013 | 0.2 | Adenylate cyclase stimulant | 0.157 0.052 CID_154699852 | ||
| 0.191 | 0.005 | 0.191 | Anabolic | 0.16 0.013 CID_154699852 | ||
| 0.244 | 0.062 | 0.244 | Antimitotic | |||
| 0.186 | 0.005 | 0.186 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.18 | 0.01 | 0.193 | Toll-Like receptor 4 antagonist | 0.193 0.007 CID_154699852 | CID_154699852 | |
| 0.176 | 0.01 | 0.176 | Aromatase inhibitor | |||
| 0.169 | 0.006 | 0.169 | Androgen agonist | 0.081 0.023 CID_154699852 | ||
| 0.246 | 0.086 | 0.639 | Antioxidant | 0.639 0.009 CID_154699852 | CID_154699852 | |
| 0.218 | 0.06 | 0.249 | Neurotrophic factor enhancer | 0.249 0.039 CID_154699852 | CID_154699852 | |
| 0.172 | 0.017 | 0.172 | Estrogen antagonist | 0.103 0.092 CID_154699852 | ||
| 0.242 | 0.089 | 0.242 | Gastrin inhibitor | 0.212 0.13 CID_154699852 | ||
| 0.153 | 0.01 | 0.153 | Vanilloid agonist | 0.087 0.052 CID_154699852 | ||
| 0.161 | 0.023 | 0.161 | Ca2+-transporting ATPase inhibitor | 0.157 0.029 CID_154699852 | ||
| 0.189 | 0.052 | 0.189 | Cholinergic | |||
| 0.169 | 0.034 | 0.169 | Adenylate cyclase inhibitor | 0.138 0.054 CID_154699852 | ||
| 0.14 | 0.006 | 0.14 | Progesterone antagonist | |||
| 0.232 | 0.1 | 0.232 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.145 | 0.017 | 0.145 | Estrogen receptor beta antagonist | |||
| 0.153 | 0.027 | 0.153 | Antineoplastic alkaloid | |||
| 0.144 | 0.018 | 0.144 | Opioid kappa receptor antagonist | |||
| 0.22 | 0.094 | 0.384 | DNA synthesis inhibitor | 0.384 0.024 CID_154699852 | CID_154699852 | |
| 0.257 | 0.139 | 0.257 | Calcium channel activator | |||
| 0.224 | 0.107 | 0.517 | Immunostimulant | 0.517 0.027 CID_154699852 | CID_154699852 | |
| 0.129 | 0.014 | 0.152 | Glycine receptor antagonist | 0.152 0.007 CID_154699852 | CID_154699852 | |
| 0.127 | 0.013 | 0.145 | Na+ K+ transporting ATPase inhibitor | 0.145 0.007 CID_154699852 | CID_154699852 | |
| 0.171 | 0.058 | 0.296 | Melanin inhibitor | 0.296 0.022 CID_154699852 | CID_154699852 | |
| 0.138 | 0.025 | 0.138 | Interleukin 2 antagonist | |||
| 0.13 | 0.019 | 0.13 | Analgesic, opioid | |||
| 0.204 | 0.094 | 0.234 | RNA-directed DNA polymerase inhibitor | 0.234 0.061 CID_154699852 | CID_154699852 | |
| 0.192 | 0.084 | 0.243 | Psychostimulant | 0.243 0.061 CID_154699852 | CID_154699852 | |
| 0.114 | 0.009 | 0.114 | Oxytocin antagonist | |||
| 0.214 | 0.111 | 0.217 | 5 Hydroxytryptamine release stimulant | 0.217 0.108 CID_154699852 | CID_154699852 | |
| 0.113 | 0.015 | 0.113 | Glycine receptor agonist | 0.106 0.018 CID_154699852 | ||
| 0.2 | 0.104 | 0.2 | Aldehyde oxidase inhibitor | |||
| 0.222 | 0.127 | 0.271 | Hypoxia-inducible factor 1 alpha inhibitor | 0.271 0.083 CID_154699852 | CID_154699852 | |
| 0.103 | 0.013 | 0.103 | Opioid agonist | |||
| 0.162 | 0.078 | 0.162 | Growth hormone agonist | |||
| 0.093 | 0.009 | 0.093 | Heme oxygenase stimulant | 0.068 0.029 CID_154699852 | ||
| 0.171 | 0.088 | 0.41 | Platelet adhesion inhibitor | 0.41 0.01 CID_154699852 | CID_154699852 | |
| 0.091 | 0.009 | 0.091 | Aldosterone antagonist | |||
| 0.183 | 0.104 | 0.671 | Angiogenesis stimulant | 0.671 0.005 CID_154699852 | CID_154699852 | |
| 0.078 | 0.004 | 0.078 | Progesterone agonist | |||
| 0.1 | 0.027 | 0.1 | Estrogen receptor alpha antagonist | |||
| 0.08 | 0.008 | 0.08 | Adenylate cyclase 1 inhibitor | |||
| 0.112 | 0.04 | 0.112 | Opioid antagonist | |||
| 0.078 | 0.007 | 0.078 | Glucocorticoid antagonist | |||
| 0.107 | 0.037 | 0.107 | Ornithine decarboxylase inhibitor | 0.086 0.061 CID_154699852 | ||
| 0.112 | 0.044 | 0.112 | Prolactin inhibitor | |||
| 0.146 | 0.08 | 0.313 | Diuretic | 0.313 0.02 CID_154699852 | CID_154699852 | |
| 0.083 | 0.017 | 0.083 | Opioid mu receptor agonist | |||
| 0.132 | 0.067 | 0.132 | Acetylcholinesterase inhibitor | |||
| 0.07 | 0.006 | 0.07 | Microtubule stabilization | 0.065 0.009 CID_154699852 | ||
| 0.078 | 0.015 | 0.085 | Lipocortins synthesis agonist | 0.085 0.01 CID_154699852 | CID_154699852 | |
| 0.096 | 0.033 | 0.096 | Keratolytic | |||
| 0.094 | 0.033 | 0.094 | Estrogen-related receptor beta agonist | |||
| 0.069 | 0.007 | 0.069 | GABA uptake inhibitor | |||
| 0.071 | 0.009 | 0.071 | RNA-directed RNA polymerase stimulant | 0.045 0.015 CID_154699852 | ||
| 0.093 | 0.034 | 0.093 | Opioid mu receptor antagonist | |||
| 0.065 | 0.006 | 0.065 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.061 0.007 CID_154699852 | ||
| 0.072 | 0.014 | 0.072 | Opioid kappa receptor agonist | |||
| 0.07 | 0.014 | 0.07 | 5-Alpha-reductase inhibitor | 0.033 0.03 CID_154699852 | ||
| 0.075 | 0.019 | 0.075 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.215 | 0.161 | 0.425 | Apoptosis antagonist | 0.425 0.032 CID_154699852 | CID_154699852 | |
| 0.064 | 0.01 | 0.064 | Vasopressin 2 antagonist | |||
| 0.113 | 0.06 | 0.113 | GABA C receptor antagonist | |||
| 0.063 | 0.011 | 0.063 | Liver X receptor alpha agonist | |||
| 0.125 | 0.075 | 0.125 | Vanilloid 1 agonist | 0.116 0.099 CID_154699852 | ||
| 0.192 | 0.145 | 0.192 | Transcription factor STAT3 inhibitor | |||
| 0.1 | 0.054 | 0.177 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.177 0.02 CID_154699852 | CID_154699852 | |
| 0.154 | 0.111 | 0.155 | P-glycoprotein inhibitor | 0.155 0.109 CID_154699852 | CID_154699852 | |
| 0.096 | 0.055 | 0.096 | ABCA1 expression enhancer | |||
| 0.055 | 0.015 | 0.055 | Parathyroid hormone antagonist | |||
| 0.065 | 0.028 | 0.065 | Bombesin 3 receptor antagonist | |||
| 0.047 | 0.01 | 0.047 | Tubulin agonist | 0.038 0.017 CID_154699852 | ||
| 0.062 | 0.026 | 0.062 | Pregnane X receptor antagonist | |||
| 0.044 | 0.008 | 0.044 | Vasopressin 1B antagonist | |||
| 0.049 | 0.013 | 0.049 | Vasopressin 1A antagonist | |||
| 0.109 | 0.074 | 0.109 | TRPA1 agonist | |||
| 0.116 | 0.081 | 0.247 | Alpha-N-acetylglucosaminidase inhibitor | 0.247 0.023 CID_154699852 | CID_154699852 | |
| 0.084 | 0.051 | 0.085 | T cell inhibitor | 0.085 0.049 CID_154699852 | CID_154699852 | |
| 0.146 | 0.115 | 0.15 | Phospholipase C inhibitor | 0.15 0.106 CID_154699852 | CID_154699852 | |
| 0.098 | 0.069 | 0.098 | GABA C receptor agonist | |||
| 0.082 | 0.052 | 0.082 | Acetylcholine nicotinic antagonist | |||
| 0.053 | 0.026 | 0.053 | Potassium channel Kv1.3 blocker | |||
| 0.173 | 0.147 | 0.173 | Cardiotonic | |||
| 0.042 | 0.018 | 0.042 | Glucose-6-phosphate dehydrogenase inhibitor | |||
| 0.026 | 0.004 | 0.043 | Telomerase stimulant | 0.043 0.002 CID_154699852 | CID_154699852 | |
| 0.062 | 0.041 | 0.068 | Transcription factor AP-1 inhibitor | 0.068 0.033 CID_154699852 | CID_154699852 | |
| 0.067 | 0.046 | 0.067 | Glutamate (mGluR6) antagonist | |||
| 0.031 | 0.011 | 0.031 | Hedgehog signaling activator | |||
| 0.049 | 0.032 | 0.049 | Mineralocorticoid receptor antagonist | |||
| 0.02 | 0.004 | 0.022 | Antibiotic Tetracycline-like | 0.022 0.003 CID_154699852 | CID_154699852 | |
| 0.039 | 0.024 | 0.039 | Farnesoid X receptor agonist | |||
| 0.049 | 0.034 | 0.049 | HCV NS3/NS4A protease inhibitor | |||
| 0.026 | 0.012 | 0.026 | Estrone sulfatase inhibitor | |||
| 0.033 | 0.02 | 0.033 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.091 | 0.078 | 0.091 | Nav1.1 sodium channel blocker | |||
| 0.148 | 0.136 | 0.148 | Insulin sensitizer | |||
| 0.182 | 0.171 | 0.182 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.13 | 0.12 | 0.145 | Heat shock protein 70 antagonist | 0.145 0.059 CID_154699852 | CID_154699852 | |
| 0.098 | 0.088 | 0.178 | DNA polymerase I inhibitor | 0.178 0.036 CID_154699852 | CID_154699852 | |
| 0.031 | 0.023 | 0.031 | Vasopressin 1 antagonist | |||
| 0.022 | 0.014 | 0.023 | Vitamin D receptor antagonist | 0.023 0.014 CID_154699852 | CID_154699852 | |
| 0.068 | 0.06 | 0.068 | CDC25A inhibitor | |||
| 0.022 | 0.014 | 0.027 | Corticosteroid-like | 0.027 0.009 CID_154699852 | CID_154699852 | |
| 0.017 | 0.01 | 0.017 | Vitamin D receptor agonist | 0.017 0.01 CID_154699852 | ||
| 0.02 | 0.013 | 0.02 | 5-Alpha-reductase 2 inhibitor | |||
| 0.16 | 0.154 | 0.438 | Spasmolytic | 0.438 0.033 CID_154699852 | CID_154699852 | |
| 0.089 | 0.083 | 0.297 | Expectorant | 0.297 0.009 CID_154699852 | CID_154699852 | |
| 0.1 | 0.095 | 0.1 | Cholinergic antagonist | |||
| 0.013 | 0.008 | 0.013 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | |||
| 0.015 | 0.01 | 0.015 | NMDA receptor phencyclidine site antagonist | |||
| 0.098 | 0.095 | 0.098 | Acetylcholine antagonist | |||
| 0.069 | 0.067 | 0.069 | Vanilloid 4 agonist | |||
| 0.138 | 0.137 | 0.138 | Succinate dehydrogenase inhibitor | |||
| 0.02 | 0.023 | 0.073 | Protein 30S ribosomal subunit inhibitor | 0.073 0.004 CID_154699852 | CID_154699852 | |
| 0.04 | 0.052 | 0.064 | Glucose-6-phosphate isomerase inhibitor | 0.064 0.015 CID_154699852 | CID_154699852 | |
| 0.043 | 0.06 | 0.086 | Alpha-mannosidase inhibitor | 0.086 0.009 CID_154699852 | CID_154699852 | |
| 0.182 | 0.201 | 0.586 | Antithrombotic | 0.586 0.018 CID_154699852 | CID_154699852 | |
| 0.135 | 0.154 | 0.297 | Hypolipemic | 0.297 0.05 CID_154699852 | CID_154699852 | |
| 0.097 | 0.12 | 0.26 | Lipid peroxidase inhibitor | 0.26 0.025 CID_154699852 | CID_154699852 | |
| 0.037 | 0.06 | 0.111 | Protein 50S ribosomal subunit inhibitor | 0.111 0.011 CID_154699852 | CID_154699852 | |
| 0.116 | 0.14 | 0.152 | CC chemokine 6 receptor antagonist | 0.152 0.02 CID_154699852 | CID_154699852 | |
| 0.019 | 0.043 | 0.031 | Vanilloid 2 agonist | 0.031 0.008 CID_154699852 | CID_154699852 | |
| 0.004 | 0.032 | 0.018 | Antibiotic Macrolide-like | 0.018 0.008 CID_154699852 | CID_154699852 | |
| 0.045 | 0.078 | 0.145 | Phosphofructokinase-1 inhibitor | 0.145 0.019 CID_154699852 | CID_154699852 | |
| 0.08 | 0.119 | 0.192 | Alkylator | 0.192 0.029 CID_154699852 | CID_154699852 | |
| 0.077 | 0.121 | 0.122 | Mucolytic | 0.122 0.053 CID_154699852 | CID_154699852 | |
| 0.121 | 0.167 | 0.227 | ATPase inhibitor | 0.227 0.021 CID_154699852 | CID_154699852 | |
| 0.083 | 0.135 | 0.213 | Cyclooxygenase 3 inhibitor | 0.213 0.015 CID_154699852 | CID_154699852 | |
| 0.072 | 0.128 | 0.093 | Glutamate release inhibitor | 0.093 0.056 CID_154699852 | CID_154699852 | |
| 0.024 | 0.081 | 0.038 | Guanylate cyclase inhibitor | 0.038 0.037 CID_154699852 | CID_154699852 | |
| 0.138 | 0.195 | 0.257 | DNA damaging | 0.257 0.076 CID_154699852 | CID_154699852 | |
| 0.025 | 0.084 | 0.071 | Mannosidase inhibitor | 0.071 0.011 CID_154699852 | CID_154699852 | |
| 0.174 | 0.24 | 0.419 | Interleukin 2 agonist | 0.419 0.022 CID_154699852 | CID_154699852 | |
| 0.061 | 0.129 | 0.126 | Triose-phosphate isomerase inhibitor | 0.126 0.029 CID_154699852 | CID_154699852 | |
| 0.008 | 0.087 | 0.04 | Arginase inhibitor | 0.04 0.022 CID_154699852 | CID_154699852 | |
| 0.124 | 0.208 | 0.235 | Cyclic AMP phosphodiesterase inhibitor | 0.235 0.072 CID_154699852 | CID_154699852 | |
| 0.01 | 0.094 | 0.022 | Antibiotic Anthracycline-like | 0.022 0.008 CID_154699852 | CID_154699852 | |
| 0.205 | 0.298 | 0.31 | 5 Hydroxytryptamine release inhibitor | 0.31 0.154 CID_154699852 | CID_154699852 | |
| 0.065 | 0.158 | 0.205 | AMP-activated protein kinase stimulant | 0.205 0.01 CID_154699852 | CID_154699852 | |
| 0.055 | 0.158 | 0.154 | UDP-glucose 4-epimerase inhibitor | 0.154 0.027 CID_154699852 | CID_154699852 | |
| 0.043 | 0.147 | 0.162 | Monophenol monooxygenase inhibitor | 0.162 0.043 CID_154699852 | CID_154699852 | |
| 0.056 | 0.163 | 0.112 | NADH dehydrogenase inhibitor | 0.112 0.033 CID_154699852 | CID_154699852 | |
| 0.082 | 0.19 | 0.233 | Cell wall synthesis inhibitor | 0.233 0.02 CID_154699852 | CID_154699852 | |
| 0.067 | 0.188 | 0.104 | Photosensitizer | 0.104 0.08 CID_154699852 | CID_154699852 | |
| 0.07 | 0.195 | 0.253 | Cell adhesion inhibitor | 0.253 0.015 CID_154699852 | CID_154699852 | |
| 0.008 | 0.135 | 0.031 | Sodium/glucose cotransporter 2 inhibitor | 0.031 0.013 CID_154699852 | CID_154699852 | |
| 0.04 | 0.179 | 0.1 | Protein-tyrosine phosphatase 1B inhibitor | 0.1 0.078 CID_154699852 | CID_154699852 | |
| 0.089 | 0.231 | 0.305 | Interleukin agonist | 0.305 0.046 CID_154699852 | CID_154699852 | |
| 0.009 | 0.162 | 0.029 | Sodium/glucose cotransporter inhibitor | 0.029 0.012 CID_154699852 | CID_154699852 | |
| 0.125 | 0.282 | 0.374 | Peptidyltransferase inhibitor | 0.374 0.009 CID_154699852 | CID_154699852 | |
| 0.05 | 0.215 | 0.136 | Beta glucuronidase inhibitor | 0.136 0.033 CID_154699852 | CID_154699852 | |
| 0.009 | 0.187 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.024 CID_154699852 | CID_154699852 | |
| 0.119 | 0.308 | 0.322 | Vasodilator, coronary | 0.322 0.071 CID_154699852 | CID_154699852 | |
| 0.044 | 0.252 | 0.081 | Thioredoxin inhibitor | 0.081 0.079 CID_154699852 | CID_154699852 | |
| 0.042 | 0.273 | 0.199 | Amylase inhibitor | 0.199 0.045 CID_154699852 | CID_154699852 | |
| 0.022 | 0.257 | 0.074 | Heparanase inhibitor | 0.074 0.009 CID_154699852 | CID_154699852 | |
| 0.06 | 0.313 | 0.154 | Hexokinase inhibitor | 0.154 0.074 CID_154699852 | CID_154699852 | |
| 0.098 | 0.374 | 0.277 | Antiobesity | 0.277 0.134 CID_154699852 | CID_154699852 | |
| 0.063 | 0.351 | 0.176 | Non-steroidal antiinflammatory agent | 0.176 0.091 CID_154699852 | CID_154699852 | |
| 0.1 | 0.405 | 0.326 | Histamine release inhibitor | 0.326 0.111 CID_154699852 | CID_154699852 | |
| 0.013 | 0.318 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 CID_154699852 | CID_154699852 | |
| 0.014 | 0.374 | 0.068 | Antibiotic Aminoglycoside-like | 0.068 0.006 CID_154699852 | CID_154699852 | |
| 0.013 | 0.375 | 0.066 | Neuraminidase (influenza) inhibitor | 0.066 0.041 CID_154699852 | CID_154699852 | |
| 0.048 | 0.423 | 0.408 | Insulin secretagoues | 0.408 0.006 CID_154699852 | CID_154699852 | |
| 0.041 | 0.422 | 0.46 | Free radical scavenger | 0.46 0.02 CID_154699852 | CID_154699852 | |
| 0.019 | 0.453 | 0.098 | ATPase (Vacuolar H+) inhibitor | 0.098 0.042 CID_154699852 | CID_154699852 | |
| 0.014 | 0.486 | 0.077 | Topoisomerase II alpha inhibitor | 0.077 0.055 CID_154699852 | CID_154699852 | |
| 0.043 | 0.523 | 0.205 | NOS3 expression enhancer | 0.205 0.039 CID_154699852 | CID_154699852 | |
| 0.031 | 0.528 | 0.158 | Hemostatic | 0.158 0.059 CID_154699852 | CID_154699852 | |
| 0.013 | 0.522 | 0.142 | Topoisomerase I inhibitor | 0.142 0.044 CID_154699852 | CID_154699852 | |
| 0.02 | 0.564 | 0.055 | Adenine nucleotide translocase inhibitor | 0.055 0.04 CID_154699852 | CID_154699852 | |
| 0.012 | 0.575 | 0.064 | Glucose-6-phosphate translocase inhibitor | 0.064 0.02 CID_154699852 | CID_154699852 | |
| 0.038 | 0.631 | 0.608 | Hypoglycemic | 0.608 0.008 CID_154699852 | CID_154699852 | |
| 0.013 | 0.649 | 0.228 | Thrombolytic | 0.228 0.04 CID_154699852 | CID_154699852 | |
| 0.017 | 0.728 | 0.265 | Tumour necrosis factor alpha release inhibitor | 0.265 0.068 CID_154699852 | CID_154699852 | |
| 0.004 | 0.787 | 0.292 | Selectin antagonist | 0.292 0.006 CID_154699852 | CID_154699852 | |
| 0.005 | 0.814 | 0.104 | Topoisomerase II inhibitor | 0.104 0.082 CID_154699852 | CID_154699852 | |
| 0.009 | 0.822 | 0.338 | Vasodilator | 0.338 0.037 CID_154699852 | CID_154699852 | |
| 0.012 | 0.848 | 0.674 | Cyclophilin D inhibitor | 0.674 0.017 CID_154699852 | CID_154699852 | |
| 0.005 | 0.875 | 0.222 | Platelet antagonist | 0.222 0.087 CID_154699852 | CID_154699852 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |